Related Experiment Video
Updated: May 27, 2026

Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment
Published on: May 6, 2020
Biotransformation enzymes and lung cell response to 2-hydroxyethyl-methacrylate
J T Samuelsen1, J A Holme, M Låg
1Nordic Institute of Dental Materials AS, PO Box 3874, Ullevaal Stadion, N-0805 Oslo, Norway. j.t.samuelsen@niom.no.
Cytochrome P450 enzymes are involved in 2-hydroxyethyl-methacrylate (HEMA) toxicity by forming reactive metabolites. Inhibiting these enzymes or using antioxidants protects cells from HEMA-induced apoptosis.
Area of Science:
- Toxicology
- Cell Biology
- Biochemistry
Background:
- 2-hydroxyethyl-methacrylate (HEMA) is a widely used monomer with potential toxic effects.
- Cytochrome P450 (CYP) enzymes play a crucial role in xenobiotic metabolism and detoxification.
- The aryl hydrocarbon receptor (AhR) pathway is implicated in cellular responses to environmental toxins.
Purpose of the Study:
- To investigate the role of CYP enzymes in HEMA's toxicity.
- To explore the involvement of the AhR pathway in HEMA-induced cellular responses.
- To identify potential protective strategies against HEMA toxicity.
Main Methods:
- In vitro study using primary rat alveolar type 2 cells.
- Exposure to varying concentrations of HEMA.
- Immunocytochemistry for nuclear translocation of AhR.
- Reverse transcriptase PCR for AhR-regulated gene expression.
- Assessment of apoptotic morphology and reactive oxygen species (ROS) levels.
- Co-treatment with a CYP inhibitor (disulfiram) and an antioxidant (vitamin C).
Main Results:
- HEMA exposure led to nuclear translocation of AhR and increased mRNA levels of AhR-regulated detoxification genes.
- 1 mM HEMA induced apoptotic-like morphology in cells within 6 hours.
- Co-treatment with disulfiram or vitamin C protected cells from HEMA-induced apoptosis.
- No significant increase in ROS levels was observed in HEMA-exposed cells.
Conclusions:
- HEMA activates AhR-regulated gene transcription.
- CYP enzymes are involved in generating a toxic HEMA metabolite.
- CYP inhibition or antioxidant treatment can mitigate HEMA-induced cellular damage.
More Related Videos
09:29An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing
Published on: May 13, 2020
11:26Harvesting Murine Alveolar Macrophages and Evaluating Cellular Activation Induced by Polyanhydride Nanoparticles
Published on: June 8, 2012
Related Concept Videos
Drug Biotransformation: Overview
Drug Biotransformation: Overview
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Bioactivation and Tissue Toxicity
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...